Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.
To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Platelet activating factor
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).
Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).
Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Tool AT et al. | Phospholipase D-derived phosphatidic acid is involved in the activation of the CD11b/CD18 integrin in human eosinophils. | 1999 | Biochem. J. | pmid:10229663 |
Hirashima Y et al. | Deficient platelet-activating factor and related enzymes in hemimegalencephaly. | 1999 | Childs Nerv Syst | pmid:10230665 |
Reinhardt JC et al. | Immunofluorescent evidence of the platelet-activating factor receptor on human spermatozoa. | 1999 | Fertil. Steril. | pmid:10231061 |
López-Novoa JM | Potential role of platelet activating factor in acute renal failure. | 1999 | Kidney Int. | pmid:10231429 |
Yamaguchi Y et al. | Platelet-activating factor antagonist (TCV-309) attenuates the priming effects of bronchoalveolar macrophages in cerulein-induced pancreatitis rats. | 1999 | Pancreas | pmid:10231840 |
Jenks PJ et al. | Comparison of weal and flare responses to platelet activating factor (PAF) and histamine, and the ultrastructural effects of PAF in the skin of atopic and normal subjects. | 1999 | Clin. Exp. Dermatol. | pmid:10233666 |
Kavakli K et al. | Plasma platelet-activating factor (PAF) levels and desmopressin response in children with hemophilia A and von Willebrand's disease. | 1999 | Thromb. Haemost. | pmid:10235463 |
Dong JC et al. | [Experimental study on antagonism of ginkgolides against effect of platelet-activating factor on lung strip of guinea pigs]. | 1997 | Zhongguo Zhong Xi Yi Jie He Za Zhi | pmid:10322836 |
Denizot Y et al. | Are lipid mediators implicated in the production of pro- and anti-inflammatory cytokines during cardiopulmonary bypass graft with extracorporeal circulation? | 1999 | Cytokine | pmid:10328869 |
Rigat B et al. | The GM2 activator protein, a novel inhibitor of platelet-activating factor. | 1999 | Biochem. Biophys. Res. Commun. | pmid:10329374 |
Flickinger BD and Olson MS | Localization of the platelet-activating factor receptor to rat pancreatic microvascular endothelial cells. | 1999 | Am. J. Pathol. | pmid:10329588 |
Mori N et al. | Ischemia-reperfusion induced microvascular responses in LDL-receptor -/- mice. | 1999 | Am. J. Physiol. | pmid:10330250 |
Rhee CK et al. | Effect of platelet activating factor and its antagonist on the mucociliary clearance of the eustachian tube in guinea pigs. | 1999 | Ann. Otol. Rhinol. Laryngol. | pmid:10335705 |
Latorre E et al. | Platelet-activating factor modulates brain sphingomyelin metabolism. | 1999 | Eur. J. Biochem. | pmid:10336612 |
Huang YH et al. | Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism. | 1999 | Clin. Exp. Immunol. | pmid:10337026 |
Markert R and Modzelewski B | [Inflammatory mediators in the acute pancreatitis]. | 1999 | Pol. Merkur. Lekarski | pmid:10337184 |
Alvi SA et al. | Corticotrophin-releasing hormone and platelet-activating factor induce transcription of the type-2 cyclo-oxygenase gene in human fetal membranes. | 1999 | Mol. Hum. Reprod. | pmid:10338371 |
Aliberti JC et al. | Platelet-activating factor induces nitric oxide synthesis in Trypanosoma cruzi-infected macrophages and mediates resistance to parasite infection in mice. | 1999 | Infect. Immun. | pmid:10338485 |
Yoshimura T et al. | Estrogen replacement therapy decreases platelet-activating factor-acetylhydrolase activity in post-menopausal women. | 1999 | Maturitas | pmid:10340285 |
McNulty CA et al. | Characterization of the integrin and activation steps mediating human eosinophil and neutrophil adhesion to chronically inflamed airway endothelium. | 1999 | Am. J. Respir. Cell Mol. Biol. | pmid:10340944 |
Nasu K et al. | Platelet-activating factor stimulates cytokine production by human endometrial stromal cells. | 1999 | Mol. Hum. Reprod. | pmid:10341002 |
Cepinskas G et al. | PAF-induced elastase-dependent neutrophil transendothelial migration is associated with the mobilization of elastase to the neutrophil surface and localization to the migrating front. | 1999 | J. Cell. Sci. | pmid:10341212 |
Mariano F et al. | Production of platelet-activating factor in patients with sepsis-associated acute renal failure. | 1999 | Nephrol. Dial. Transplant. | pmid:10344354 |
Rainsford KD | Inhibition by leukotriene inhibitors, and calcium and platelet-activating factor antagonists, of acute gastric and intestinal damage in arthritic rats and in cholinomimetic-treated mice. | 1999 | J. Pharm. Pharmacol. | pmid:10344635 |
Cruzado JM et al. | Effect of human natural xenoantibody depletion and complement inactivation on early pig kidney function. | 1999 May-Jun | Exp. Nephrol. | pmid:10352362 |
Svetlov SI et al. | Decreased intraplatelet Ca2+ release and ATP secretion in pediatric nephrotic syndrome. | 1999 | Pediatr. Nephrol. | pmid:10353406 |
Weber C et al. | Effects of oxidized low density lipoprotein, lipid mediators and statins on vascular cell interactions. | 1999 | Clin. Chem. Lab. Med. | pmid:10353467 |
Del Sorbo L et al. | The synthesis of platelet-activating factor modulates chemotaxis of monocytes induced by HIV-1 Tat. | 1999 | Eur. J. Immunol. | pmid:10359105 |
Crawford SE et al. | Captopril and platelet-activating factor (PAF) antagonist prevent cardiac allograft vasculopathy in rats: role of endogenous PAF and PAF-like compounds. | 1999 | J. Heart Lung Transplant. | pmid:10363692 |
Goldman R et al. | Calcium-dependent PAF-stimulated generation of reactive oxygen species in a human keratinocyte cell line. | 1999 | Biochim. Biophys. Acta | pmid:10366777 |
Steil AA et al. | Platelet-activating factor and eicosanoids are mediators of local and systemic changes induced by immune-complexes in mice. | 1999 | Prostaglandins Other Lipid Mediat. | pmid:10367295 |
MartÃnez L et al. | Nitroprusside stimulates contractility and the synthesis of 14C-acetylated PAF-like substances in estrogen primed-mouse uterine horns. | 1999 | Prostaglandins Other Lipid Mediat. | pmid:10367296 |
Cahana A and Reiner O | LIS1 and platelet-activating factor acetylhydrolase (Ib) catalytic subunits, expression in the mouse oocyte and zygote. | 1999 | FEBS Lett. | pmid:10371146 |
Diaz E et al. | Presence of platelet-activating factor in rhesus (Macaca mulatta) spermatozoa. | 1999 | J. Med. Primatol. | pmid:10372538 |
Rosenbaum JT et al. | Intravitreally injected platelet activating factor induces retinitis in experimental animals. | 1999 | Curr. Eye Res. | pmid:10372995 |
Xiao J et al. | Synergetic protective effects of combined blockade by two kinds of autolesion mediator receptor on neurological function after cervical cord injury. | 1998 | Chin. Med. J. | pmid:10374355 |
Ji Z et al. | [The role of platelet activating factor in pathogenesis of acute pancreatitis in dogs]. | 1997 | Zhonghua Wai Ke Za Zhi | pmid:10374489 |
Yi FX and Guo ZG | Platelet-released ADP stabilizes PAF-induced rabbit platelet aggregation by stabilizing intracellular calcium. | 1998 | Zhongguo Yao Li Xue Bao | pmid:10375790 |
Wang Y et al. | Increased neutrophil-endothelial adhesion induced by placental factors is mediated by platelet-activating factor in preeclampsia. | 1999 May-Jun | J. Soc. Gynecol. Investig. | pmid:10376269 |
Callea L et al. | Platelet activating factor is elevated in cerebral spinal fluid and plasma of patients with relapsing-remitting multiple sclerosis. | 1999 | J. Neuroimmunol. | pmid:10376955 |
McNeil RS et al. | Neuronal cytoskeletal alterations evoked by a platelet-activating factor (PAF) analogue. | 1999 | Cell Motil. Cytoskeleton | pmid:10379835 |
Deigner HP et al. | Novel reversible, irreversible and fluorescent inhibitors of platelet-activating factor acetylhydrolase as mechanistic probes. | 1999 | Atherosclerosis | pmid:10381281 |
Bandeira-Melo C et al. | Suppressive effect of distinct bradykinin B2 receptor antagonist on allergen-evoked exudation and leukocyte infiltration in sensitized rats. | 1999 | Br. J. Pharmacol. | pmid:10385228 |
Guilbert M et al. | 5-Oxo-6,8,11,14-eicosatetraenoic acid induces important eosinophil transmigration through basement membrane components: comparison of normal and asthmatic eosinophils. | 1999 | Am. J. Respir. Cell Mol. Biol. | pmid:10385597 |
Fujii E et al. | Microvascular permeability change induced by platelet-activating factor is impaired in diabetic mice. | 1999 | Microvasc. Res. | pmid:10388605 |
Forte TM et al. | Targeted disruption of the murine lecithin:cholesterol acyltransferase gene is associated with reductions in plasma paraoxonase and platelet-activating factor acetylhydrolase activities but not in apolipoprotein J concentration. | 1999 | J. Lipid Res. | pmid:10393212 |
Subramanian VS et al. | Role of lecithin-cholesterol acyltransferase in the metabolism of oxidized phospholipids in plasma: studies with platelet-activating factor-acetyl hydrolase-deficient plasma. | 1999 | Biochim. Biophys. Acta | pmid:10395969 |
Kulikov VI and Muzya GI | Mechanisms of interaction of a plasmalogenic analog of platelet-activating factor with human platelets. | 1999 | Biochemistry Mosc. | pmid:10395976 |
Strukova SM et al. | Modulation of mast cell activity by a peptide agonist of the thrombin receptor: role of nitric oxide. | 1999 | Biochemistry Mosc. | pmid:10395981 |
Ishii S and Shimizu T | [Platelet-activating factor (PAF) receptor-related pathophysiology]. | 1999 | Tanpakushitsu Kakusan Koso | pmid:10396985 |